[{"Assets_0_Q3_USD":347101000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-53374000.0,"NetIncomeLoss_1_Q3_USD":-24406000.0,"NetIncomeLoss_3_Q3_USD":-60647000.0,"PaymentsOfDividendsCommonStock_3_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":318913000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]